Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,873
-$4,409 QoQ
Shares Held
20,995
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#183
of 258 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jasper Ridge Partners, L.P. holds $9,938,193 across 12 Biotechnology names. GERN ranks #12 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
42,455 | $2,335,025 | |
| 2 | NRIX |
Nurix Therapeutics, Inc.
|
95,711 | $2,321,948 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
13,845 | $1,537,210 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
5,809 | $1,087,909 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
6,248 | $731,453 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
9,539 | $520,257 | |
| 7 | CYTK |
Cytokinetics Inc
|
5,500 | $468,545 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
10,154 | $435,708 |
All Filings in GERN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,873 | 20,995 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $31,282 | 20,995 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $27,713 | 20,995 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $44,486 | 32,472 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $45,785 | 32,472 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $51,630 | 32,472 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $114,950 | 32,472 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $147,422 | 32,472 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $137,681 | 32,472 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $107,157 | 32,472 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||